Simplifying Global Compliance
FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations
TELA Bio Launches OviTex Portfolio
July 15, 2016
TELA Bio has launched its OviTex portfolio, a suite of products intended for ventral hernia repair and abdominal wall reconstruction.
The portfolio consists of six products with a range of sizes, thicknesses and degrees of reinforcement. — Anisa Jibrell
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing